Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Immuneering (IMRX) Non Operating Income (2021 - 2024)

Immuneering (IMRX) has 4 years of Non Operating Income data on record, last reported at $91430.0 in Q4 2024.

  • For Q4 2024, Non Operating Income fell 80.31% year-over-year to $91430.0; the TTM value through Dec 2024 reached $441493.0, down 66.91%, while the annual FY2024 figure was $441493.0, 66.91% down from the prior year.
  • Non Operating Income reached $91430.0 in Q4 2024 per IMRX's latest filing, down from $129309.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $475595.0 in Q3 2023 and bottomed at -$118974.0 in Q4 2021.
  • Average Non Operating Income over 4 years is $133253.1, with a median of $125072.0 recorded in 2022.
  • Peak YoY movement for Non Operating Income: surged 1593.82% in 2022, then tumbled 94.86% in 2024.
  • A 4-year view of Non Operating Income shows it stood at -$118974.0 in 2021, then surged by 287.67% to $223280.0 in 2022, then surged by 107.97% to $464352.0 in 2023, then tumbled by 80.31% to $91430.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $91430.0 in Q4 2024, $129309.0 in Q3 2024, and $7717.0 in Q2 2024.